Evaluating the Impact of Artificial Intelligence on Ethics in Pharmacy Practice: A Systematic Review

Abstract

Background: The influence of artificial intelligence (AI) across different spheres of life continues to increase, and the pharmacy profession has not been left behind. Across research in different countries, AI emerges as an instrumental technology transforming how pharmacy professionals undertake their routine duties. However, with the increase in the use of AI in pharmacy practice emerges a critical need to understand the ethical implications that this new trend has within the pharmacy sector. The purpose of the current study was to systematically review published studies to understand how the adoption of AI in pharmacy practice impacts ethical practice from the perspectives of the challenges it presents, its influence in decision-making and the existing regulatory frameworks, and understand possible solutions to challenges emerging within the pharmacy profession as a result of increasing adoption of AI. Methods: Using PRISMA guidelines, the researcher conducted a systematic review of articles published between 2014 and 2024 and which were focused on elements of ethical implications of AI for its adoption and application within the pharmacy practice. Four electronic databases; PubMed, Scopus, Web of Science, and Google Scholar were searched for data sources, from which a total of3732 articles emerged from the initial search. Upon screening for suitability, 17 articles remained and were systematically reviewed. Data extraction and synthesis was carried out and summarized in a standard Table. Results: The review revealed a dual impact of AI in pharmacy practice, enhancing efficiency while posing ethical risks. It emerged that AI-driven decision-making tools serve to improve medication safety but at the same time do require robust ethical frameworks for the purpose of ensuring fairness, transparency, and accountability. Conclusions: The findings point to the conclusion that there is a need for continued ethical discourse, regulatory development, and pharmacist education from all relevant stakeholders for the purpose of maximizing AI’s benefits while mitigating risks.

Ähnliche Arbeiten